Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2725 (LINC02725) is a human long intergenic non-protein coding RNA (lincRNA), which is a type of long non-coding RNA located outside of protein-coding regions.[1][3] LincRNAs such as LINC02725 are typically more than 200 nucleotides long and modulate gene expression by diverse mechanisms including chromatin remodeling, scaffolding of protein complexes, and cis- or trans-regulation of transcription. LINC02725 itself has been identified in cancer-related transcriptomic studies, and its expression level has been included in multi-lncRNA signatures predictive for patient prognosis in breast cancer, though its precise biological role and mechanistic function are not yet well characterized.[4][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2725 (LINC02725).